Femasys Inc. (NASDAQ:FEMY – Get Rating)'s stock price fell 0.8% during trading on Tuesday . The company traded as low as $1.18 and last traded at $1.21. 2,561 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 8,797 shares. The stock had previously closed at $1.22.
Analyst Ratings Changes
FEMY has been the subject of a number of recent analyst reports. Chardan Capital dropped their price target on shares of Femasys from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, November 11th. HC Wainwright dropped their price target on shares of Femasys from $8.00 to $5.00 and set a "buy" rating for the company in a research note on Thursday, October 20th.
Get Femasys alerts:Femasys Stock Performance
The company has a market capitalization of $14.30 million, a PE ratio of -1.53 and a beta of -0.23. The company has a current ratio of 9.56, a quick ratio of 9.37 and a debt-to-equity ratio of 0.01. The firm's 50-day simple moving average is $1.10 and its 200-day simple moving average is $1.41.
Femasys (NASDAQ:FEMY – Get Rating) last released its quarterly earnings data on Thursday, November 10th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.02). The company had revenue of $0.35 million during the quarter, compared to analysts' expectations of $0.40 million. Femasys had a negative net margin of 886.22% and a negative return on equity of 48.96%. On average, research analysts predict that Femasys Inc. will post -0.98 earnings per share for the current year.Institutional Investors Weigh In On Femasys
Several large investors have recently added to or reduced their stakes in the stock. Cetera Advisor Networks LLC bought a new stake in shares of Femasys in the 1st quarter valued at about $27,000. Virtu Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $39,000. HB Wealth Management LLC bought a new stake in shares of Femasys in the 4th quarter valued at about $49,000. LPL Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $51,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Femasys in the 1st quarter valued at about $68,000. 7.49% of the stock is owned by hedge funds and other institutional investors.
About Femasys
(Get Rating)
Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.
See Also
- Get a free copy of the StockNews.com research report on Femasys (FEMY)
- Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
- Dividend King Sysco: Buying On The Dip
- Is the 1,600% Rise in Genius Group Stock Justified?
- After Further Review, Investors Liked Exxon Mobil's Earnings
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.